An interventional study of Mulligan mobilization with arm movement and conventional therapy of cevical radiculopathy in Cairo University, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-04-27.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 36 studies in Radiculopathy by Cairo University — 22 open to participants now, 22 under way, none of them phase 3. Radiculopathy · Cairo University.
Among the 36 studies in Radiculopathy by Cairo University, this one is the 16th largest by planned enrollment of the 27 interventional ones that give a count, is one of 5 that started in 2025, is one of 26 with no phase, reaches primary completion later than 8 of the 21 other live ones, and was the 15th registered.
488 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.
Browse Radiculopathy studies →22 of the 36 studies in Radiculopathy by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 25–44
Cairo University · Sites in Egypt
Ages 35–50 · Men only
Cairo University · Sites in Egypt
Ages 40–60
Cairo University · Sites in Egypt
Ages 36–46
Cairo University · Sites in Egypt
Ages 40–55
By country, each count listing its studies:
Of the 79 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 48 (61%) stop at 75 or younger; 3 take children under 18; 7 take healthy volunteers.
This study: 20 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
36 studies; the count open now beside each. This study's row is marked.
First in 2019; this study’s year is marked. 5 started in 2025.
This study's planned enrollment of 40 is below the median of 60 across 375 interventional studies indexed under Radiculopathy.
Median enrollment 45 across the 27 interventional studies, 66 across the 9 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
5 of the studies in Radiculopathy by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07906847Cairo UniversityCorrelation Between Forward Head Posture and Executive Functions in Cervical Radiculopathy | 2027-01 |
| NCT07841405Cairo UniversityEffect of Transfer of Energy Capacitive and Resistive on Chronic Discogenic Sciatica | 2027-01-21 |
| NCT07949279Cairo UniversityMovement Patterns and Balance in People With Lumbar Radiculopathy | 2027-02-28 |
| NCT07946133Cairo UniversityELDOA Versus GPR Exercises in Cervical Radiculopathy | 2027-04-30 |
| NCT07817992Cairo UniversityEffect of Virtual Reality- Based Training on Cervical Mobility, Proprioceptive Accuracy and Hand Grip Strength in Patients With Cervical Radiculopathy | 2027-07-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 36 studies in Radiculopathy by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to investigate the effect of Mulligan mobilization with arm movement on nerve conduction velocity in patients with unilateral cervical radiculopathy. The main questions it aims to answer are :
The course of treatment involves 6 sessions over the course of 3 weeks participants will be divided into 2 groups : Control group : recieves only Conventional treatment Experimental group : recieves Conventional treatment and Mulligan mobilization with arm movement .
the aim of our study is to examine the effect of Mulligan mobilization with arm movement on cervical radiculopathy using nerve conduction studies , in addition to the original measures of previous studies (pain level, cervical ROM and neck disability scale) .
Delimitations :
Inclusion Criteria
Individuals will be enrolled into the study if they are :
Exclusion Criteria .
Outcome measure would include:
A) The primary outcome measure will be NCV velocity, for the median nerve (latency, amplitude, Duration , F-wave and nerve conduction velocity of motor nerve action potentials and sensory nerve action potentials (SNAPs)) .
B) Secondary outcome measures will include:
pre-treatment for both groups :
participants will be divided into 2 groups :
Group A- Control group:
During each session : only Conventional treatment will be provided , includes : hot pack for 10 minutes, active ranges of motion (AROMs) with 3 sets of 10 repetitions and isometrics for each movement repeated 20 times with the hold of 6 to 10 seconds in each repetition.
Group B- Experimental group- Mulligan mobilization group:
During each session :
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
diagnosed with cervical radiculopathy .
Exclusion Criteria:
History of trauma, dislocation and subluxation of upper extremity
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
20 participants recieving conventional therapy in addition to mulligan mobilization with arm movement
Other: Mulligan mobilization with arm movement · Other: conventional therapy of cevical radiculopathy
control group that revieves only the conventional therapy
Other: conventional therapy of cevical radiculopathy
mulligan mobilization applied on cervical spine with arm movement
hot pack for 10 minutes, active ranges of motion (AROMs) with 3 sets of 10 repetitions and isometrics for each movement repeated 20 times with the hold of 6 to 10 seconds in each repetition
median nerve conduction study
using nerve conduction studies to measure the median nerve (latency, amplitude, Duration , F-wave and nerve conduction velocity of motor nerve action potentials and sensory nerve action potentials ) .
Time frame: 2 weeks
cervical range of motion
using cervical CROM device to measure the cervical ROM in all 3 planes
Time frame: 2 weeks
pain
using visual analogue scale for the pain intensity .. where no pain or discomfort(0) , while the severest pain (10) .. the more the pain , the more the points on the scale
Time frame: 2 weeks
neck disability level
using neck disability index questionnaire consists of 10 items, where each item is scored on a scale of 0 to 5, with 0 indicating no disability and 5 indicating complete disability * The total score ranges from 0 to 50. * Higher scores indicate greater disability and impairment, while lower scores indicate less disability.
Time frame: 2 weeks
Ran from Jan 2025 to primary completion in Mar 2025, 2 months.
Of 205 non-industry interventional studies with no phase under Radiculopathy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's 2 months is below that.
Counting every sponsor, half of 217 studies reached it within 12 months; a quarter within 5 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.